Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 14, 2026
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $124 as of August 14, 2026. Its market cap has decreased by -99.09% in one year.
Market Cap
124.00
Enterprise Value
-1.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 124.00, a decrease of -100.00%. That is a compound annual growth rate of -89.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 124.00 | -99.10% |
| Dec 31, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiromic BioPharma | 157.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| HEALTHeUNIVERSE | 118.00 |
| ObsEva | 117.00 |